EMERGENT BIOSOLUTION EBS (NYSE) $ 20.34 Change: +1.72 +8.46% | Volume: 674,072
Sponsored by Click here!

EMERGENT BIOSUL - Fundamental Profile

Company Information

Ticker Symbol: EBS
Exchange: NYSE
Contact Info: 2273 Research Boulevard Rockville MD 20850 301 795-1800
CEO/President:
Industry: Medical - Biomedical / Standard Industry Code: 2834
Description: EMERGENT BIOSULUTIONS INC. is a leading biopharmaceutical company dedicated to one simple mission - to protect life. EBS develops, manufactures and commercializes vaccines and therapeutics that assist the body's immune system to prevent or treat disease. Their products target infectious diseases and other medical conditions that have resulted in significant unmet or underserved public health needs. Their marketed product, BioThrax' (Anthrax Vaccine Adsorbed), is the only vaccine approved by the U.S. Food and Drug Administration for the prevention of anthrax infection.

Share Information

Shares Outstanding: 29,810 (000) Market Value: 547,590 ($000)
Percentage of Inst.Shareholders: 28.39% Number of Inst.Shareholders: 55.10%
Last Quarter Sales: 56.60 ($Mil.) Last Quarter Net Income: 10.39 ($Mil.)
Last Quarter EPS: 0.34 P/E Ratio: 12
Most Recent Earnings: 0.35 on 11/06/08 Earnings Per Share: 1.57
Most Recent Split: Annual Dividend Rate: 0
Most Recent Dividend: Annual Dividend Yield: 0%
Data Provided By Barchart.com
CoreData does not represent, warrant, or guarantee completeness, accuracy or timeliness of its data, and shall have no liability of any kind whatsoever to any party on account of any incompleteness of, inaccuracies in or untimeliness of the CoreData content provided hereunder, or for any delay in reporting such data. CoreData expressly disclaims all warranties of fitness of the CoreData content or computations and analyses thereof for a particular purpose or use.
advertisement

Top Competitors

AMGEN INC. +9.10 56.09
GILEAD SCIENCES -1.80 45.91
CELGENE CORPORA -8.00 58.56
BIOGEN IDEC INC -31.90 43.13
STEMCELLS INC. -56.40 1.23